223 related articles for article (PubMed ID: 24090311)
1. Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.
Vidler LR; Filippakopoulos P; Fedorov O; Picaud S; Martin S; Tomsett M; Woodward H; Brown N; Knapp S; Hoelder S
J Med Chem; 2013 Oct; 56(20):8073-88. PubMed ID: 24090311
[TBL] [Abstract][Full Text] [Related]
2. Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking.
Zhao H; Gartenmann L; Dong J; Spiliotopoulos D; Caflisch A
Bioorg Med Chem Lett; 2014 Jun; 24(11):2493-6. PubMed ID: 24767840
[TBL] [Abstract][Full Text] [Related]
3. Potent and selective bivalent inhibitors of BET bromodomains.
Waring MJ; Chen H; Rabow AA; Walker G; Bobby R; Boiko S; Bradbury RH; Callis R; Clark E; Dale I; Daniels DL; Dulak A; Flavell L; Holdgate G; Jowitt TA; Kikhney A; McAlister M; Méndez J; Ogg D; Patel J; Petteruti P; Robb GR; Robers MB; Saif S; Stratton N; Svergun DI; Wang W; Whittaker D; Wilson DM; Yao Y
Nat Chem Biol; 2016 Dec; 12(12):1097-1104. PubMed ID: 27775716
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis.
Myrianthopoulos V; Gaboriaud-Kolar N; Tallant C; Hall ML; Grigoriou S; Brownlee PM; Fedorov O; Rogers C; Heidenreich D; Wanior M; Drosos N; Mexia N; Savitsky P; Bagratuni T; Kastritis E; Terpos E; Filippakopoulos P; Müller S; Skaltsounis AL; Downs JA; Knapp S; Mikros E
J Med Chem; 2016 Oct; 59(19):8787-8803. PubMed ID: 27617704
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel BRD4 inhibitors by high-throughput screening, crystallography, and cell-based assays.
Sun Z; Zhang H; Chen Z; Xie Y; Jiang H; Chen L; Ding H; Zhang Y; Jiang H; Zheng M; Luo C
Bioorg Med Chem Lett; 2017 May; 27(9):2003-2009. PubMed ID: 28347667
[TBL] [Abstract][Full Text] [Related]
6. Straightforward hit identification approach in fragment-based discovery of bromodomain-containing protein 4 (BRD4) inhibitors.
Borysko P; Moroz YS; Vasylchenko OV; Hurmach VV; Starodubtseva A; Stefanishena N; Nesteruk K; Zozulya S; Kondratov IS; Grygorenko OO
Bioorg Med Chem; 2018 Jul; 26(12):3399-3405. PubMed ID: 29764756
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors.
Raj U; Kumar H; Varadwaj PK
J Biomol Struct Dyn; 2017 Aug; 35(11):2351-2362. PubMed ID: 27494802
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore-based virtual screening, molecular docking, molecular dynamics simulation, and biological evaluation for the discovery of novel BRD4 inhibitors.
Yan G; Hou M; Luo J; Pu C; Hou X; Lan S; Li R
Chem Biol Drug Des; 2018 Feb; 91(2):478-490. PubMed ID: 28901664
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided design.
Duffy BC; Liu S; Martin GS; Wang R; Hsia MM; Zhao H; Guo C; Ellis M; Quinn JF; Kharenko OA; Norek K; Gesner EM; Young PR; McLure KG; Wagner GS; Lakshminarasimhan D; White A; Suto RK; Hansen HC; Kitchen DB
Bioorg Med Chem Lett; 2015 Jul; 25(14):2818-23. PubMed ID: 26022843
[TBL] [Abstract][Full Text] [Related]
10. NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds.
Yu JL; Chen TT; Zhou C; Lian FL; Tang XL; Wen Y; Shen JK; Xu YC; Xiong B; Zhang NX
Acta Pharmacol Sin; 2016 Jul; 37(7):984-93. PubMed ID: 27238211
[TBL] [Abstract][Full Text] [Related]
11. Structure-based virtual screening of novel, high-affinity BRD4 inhibitors.
Muvva C; Singam ER; Raman SS; Subramanian V
Mol Biosyst; 2014 Jul; 10(9):2384-97. PubMed ID: 24976024
[TBL] [Abstract][Full Text] [Related]
12. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT.
Yu Z; Ku AF; Anglin JL; Sharma R; Ucisik MN; Faver JC; Li F; Nyshadham P; Simmons N; Sharma KL; Nagarajan S; Riehle K; Kaur G; Sankaran B; Storl-Desmond M; Palmer SS; Young DW; Kim C; Matzuk MM
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33637650
[TBL] [Abstract][Full Text] [Related]
13. Discovery of an MLLT1/3 YEATS Domain Chemical Probe.
Moustakim M; Christott T; Monteiro OP; Bennett J; Giroud C; Ward J; Rogers CM; Smith P; Panagakou I; Díaz-Sáez L; Felce SL; Gamble V; Gileadi C; Halidi N; Heidenreich D; Chaikuad A; Knapp S; Huber KVM; Farnie G; Heer J; Manevski N; Poda G; Al-Awar R; Dixon DJ; Brennan PE; Fedorov O
Angew Chem Int Ed Engl; 2018 Dec; 57(50):16302-16307. PubMed ID: 30288907
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of 2D Difference Intensity Analysis for Chemical Library Screening by Protein-Detected NMR Spectroscopy.
Egner JM; Jensen DR; Olp MD; Kennedy NW; Volkman BF; Peterson FC; Smith BC; Hill RB
Chembiochem; 2018 Mar; 19(5):448-458. PubMed ID: 29239081
[TBL] [Abstract][Full Text] [Related]
15. PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.
Picaud S; Da Costa D; Thanasopoulou A; Filippakopoulos P; Fish PV; Philpott M; Fedorov O; Brennan P; Bunnage ME; Owen DR; Bradner JE; Taniere P; O'Sullivan B; Müller S; Schwaller J; Stankovic T; Knapp S
Cancer Res; 2013 Jun; 73(11):3336-46. PubMed ID: 23576556
[TBL] [Abstract][Full Text] [Related]
16. An Overview on Small Molecule Inhibitors of BRD4.
Huang W; Zheng X; Yang Y; Wang X; Shen Z
Mini Rev Med Chem; 2016; 16(17):1403-1414. PubMed ID: 27290915
[TBL] [Abstract][Full Text] [Related]
17. Machine-Learning-Assisted Approach for Discovering Novel Inhibitors Targeting Bromodomain-Containing Protein 4.
Xing J; Lu W; Liu R; Wang Y; Xie Y; Zhang H; Shi Z; Jiang H; Liu YC; Chen K; Jiang H; Luo C; Zheng M
J Chem Inf Model; 2017 Jul; 57(7):1677-1690. PubMed ID: 28636361
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a Small-Molecule Bromodomain-Containing Protein 4 (BRD4) Inhibitor That Induces AMP-Activated Protein Kinase-Modulated Autophagy-Associated Cell Death in Breast Cancer.
Ouyang L; Zhang L; Liu J; Fu L; Yao D; Zhao Y; Zhang S; Wang G; He G; Liu B
J Med Chem; 2017 Dec; 60(24):9990-10012. PubMed ID: 29172540
[TBL] [Abstract][Full Text] [Related]
19. Design and characterization of bivalent BET inhibitors.
Tanaka M; Roberts JM; Seo HS; Souza A; Paulk J; Scott TG; DeAngelo SL; Dhe-Paganon S; Bradner JE
Nat Chem Biol; 2016 Dec; 12(12):1089-1096. PubMed ID: 27775715
[TBL] [Abstract][Full Text] [Related]
20. Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.
Hay DA; Fedorov O; Martin S; Singleton DC; Tallant C; Wells C; Picaud S; Philpott M; Monteiro OP; Rogers CM; Conway SJ; Rooney TP; Tumber A; Yapp C; Filippakopoulos P; Bunnage ME; Müller S; Knapp S; Schofield CJ; Brennan PE
J Am Chem Soc; 2014 Jul; 136(26):9308-19. PubMed ID: 24946055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
